Agilent to Announce Second-Quarter Fiscal Year 2024 Financial Results May 29

5/2/24 11:45:00 AM ET

Biotechnology: Laboratory Analytical Instruments

Industrials

Get the next $A alert in real time by email

Agilent Technologies Inc. (NYSE:A) will release financial results for the second quarter of fiscal year 2024 after the stock market closes on May 29. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PT.

To join the listen-only conference call webcast, click the link on the Events section of Agilent's investor relations website. A recording of the call will also be available on the website for 90 days.

About Agilent Technologies

Agilent Technologies Inc. (NYSE:A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent's full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240501422274/en/

Get the next $A alert in real time by email

Date	Price Target	Rating	Analyst
8/28/2024	$157.00	Overweight	Wells Fargo
7/10/2024	$135.00 → $150.00	Neutral → Buy	Citigroup
6/27/2024		Outperform → Peer Perform	Wolfe Research
6/3/2024	$135.00	Hold	Jefferies
4/5/2024	$145.00 → $163.00	Hold → Buy	Stifel
12/13/2023	$140.00	Outperform	Wolfe Research
12/12/2023	$130.00 → $133.00	Buy → Neutral	BofA Securities
11/17/2023	$163.00 → $125.00	Buy → Neutral	UBS

Agilent to Announce Second-Quarter Fiscal Year 2024 Financial Results May 29

Chat with this insight

Recent Analyst Ratings for $A

$A Market Insights

Live Market Insights

(A) - Analyzing Agilent Technologies's Short Interest

Agilent Technologies To Acquire BIOVECTRA For $925M, Expanding End-To-End Biopharma Solutions For Accelerated Drug Discovery And Development

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,200 Today

$A Financials

Live finance-specific insights

Agilent Increases Cash Dividend to 24.8 Cents per Share

Agilent to Announce Fourth-Quarter Fiscal Year 2024 Financial Results on Nov. 25

Agilent Announces Cash Dividend of 23.6 Cents per Share

$A Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Senior Vice President Riemann Angelica was granted 1,045 shares and covered exercise/tax liability with 327 shares, increasing direct ownership by 5% to 15,896 units (SEC Form 4)

Sr. VP and CFO Mcmahon Robert W. was granted 7,835 shares and covered exercise/tax liability with 2,196 shares, increasing direct ownership by 4% to 166,115 units (SEC Form 4)

President and CEO Mcdonnell Padraig was granted 4,505 shares and covered exercise/tax liability with 1,506 shares, increasing direct ownership by 13% to 26,355 units (SEC Form 4)

$A Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

$A Large Ownership Changes

This live feed shows all institutional transactions in real time.

$A SEC Filings

$A Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Wells Fargo initiated coverage on Agilent with a new price target

Agilent upgraded by Citigroup with a new price target

Agilent downgraded by Wolfe Research

Amendment: SEC Form SC 13G/A filed by Agilent Technologies Inc.

SEC Form SC 13G filed by Agilent Technologies Inc.

SEC Form SC 13G filed by Agilent Technologies Inc.

Agilent Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

SEC Form 424B5 filed by Agilent Technologies Inc.

SEC Form 8-K filed by Agilent Technologies Inc.

SEC Form 4 filed by Gonsalves Rodney (Amendment)

Gonsalves Rodney bought $288 worth of shares (3 units at $111.09), increasing direct ownership by 0.01% to 24,222 units (SEC Form 4)

$A Press Releases

Fastest customizable press release news feed in the world

Agilent Increases Cash Dividend to 24.8 Cents per Share

Agilent 2024 Early Career Professor Award Presented to Adeyemi Adeleye

Agilent Announces the Innovative Mito-rOCR Assay Kit for Mitochondrial Research

$A Leadership Updates

Live Leadership Updates

Agilent to Acquire North American CDMO BIOVECTRA

Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company's Full Potential

Agilent Unveils the 8850 Gas Chromatograph: A Leap Forward in Analytical Excellence

Recent Analyst Ratings for
$A

$A
Market Insights

$A
Financials

$A
Insider Trading

$A
Analyst Ratings

$A
Large Ownership Changes

$A
SEC Filings

$A
Insider Purchases

$A
Press Releases

$A
Leadership Updates